Ventriculostomy-related intracranial hemorrhage following surgical and endovascular treatment of ruptured aneurysms.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 23 12 2021
accepted: 22 03 2022
revised: 22 02 2022
pubmed: 30 4 2022
medline: 6 8 2022
entrez: 29 4 2022
Statut: ppublish

Résumé

Endovascular therapy of ruptured aneurysms is regularly accompanied by periprocedural heparinization and requires the use of periprocedural antiplatelets in more complex cases. This raises concerns regarding increased bleeding risks in the case of frequently required ventriculostomy. The aim of this study was to analyze risk factors for ventriculostomy-related intracranial hemorrhages (VS-ICH) in endovascular or surgical treatment of ruptured aneurysms with a focus on antithrombotic therapy. In this retrospective analysis, we included patients admitted to our institution over a 12-year period who had received at least one ventriculostomy due to subarachnoid hemorrhage-related hydrocephalus. Patients were dichotomized into an endovascular and surgical group and rates of VS-ICH were compared. Risk factors for VS-ICH were assessed in uni- and multivariate analyses. A total of 606 ventriculostomies were performed in 328 patients. Within the endovascular group, antiplatelet therapy was used in 44.8% of cases. The overall rate of ventriculostomy-related intracranial hemorrhage was 13.1%. Endovascular treatment was associated with a higher rate of VS-ICH compared to surgical treatment (p = 0.011), but not in cases without antiplatelet therapy (p = 0.166). Application of any antiplatelet therapy (odds ratio, 2.647 [95% confidence interval, 1.141-6.143]) and number of ventriculostomies (odds ratio, 2.513 [95% confidence interval, 1.859-3.395]) were independent predictors of ventriculostomy-related hemorrhages. Our findings indicate an increased risk of VS-ICH in the endovascular group if administration of antiplatelets was required. While this aspect has to be included into treatment decision-making, it must be weighed against the benefits of endovascular techniques.

Identifiants

pubmed: 35486198
doi: 10.1007/s10143-022-01777-5
pii: 10.1007/s10143-022-01777-5
pmc: PMC9349088
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2787-2795

Informations de copyright

© 2022. The Author(s).

Références

Amenta PS, Dalyai RT, Kung D, Toporowski A, Chandela S, Hasan D, Gonzalez LF, Dumont AS, Tjoumakaris SI, Rosenwasser RH (2012) Stent-assisted coiling of wide-necked aneurysms in the setting of acute subarachnoid hemorrhage: experience in 65 patients. Neurosurgery 70(6):1415–1429. https://doi.org/10.1227/NEU.0b013e318246a4b1
doi: 10.1227/NEU.0b013e318246a4b1 pubmed: 22186840
Bruder M, Schuss P, Konczalla J, El-Fiki A, Lescher S, Vatter H, Seifert V, Güresir E (2015) Ventriculostomy-related hemorrhage after treatment of acutely ruptured aneurysms: the influence of anticoagulation and antiplatelet treatment. World Neurosurg 84(6):1653–1659. https://doi.org/10.1016/j.wneu.2015.07.003
doi: 10.1016/j.wneu.2015.07.003 pubmed: 26183133
Cagnazzo F, di Carlo DT, Petrella G, Perrini P (2020) Ventriculostomy-related hemorrhage in patients on antiplatelet therapy for endovascular treatment of acutely ruptured intracranial aneurysms. A meta-analysis Neurosurgical Rev 43(2):397–406. https://doi.org/10.1007/s10143-018-0999-0
doi: 10.1007/s10143-018-0999-0
Cohen JE, Gomori JM, Leker RR, Spektor S, Abu El Hassan H, Itshayek E (2018) Stent and flow diverter assisted treatment of acutely ruptured brain aneurysms. J Neurointerv Surg 10(9):851–858. https://doi.org/10.1136/neurintsurg-2017-013742
doi: 10.1136/neurintsurg-2017-013742 pubmed: 29778996
Cheung NK, Carr MW, Ray U, McKenzie D, Froelich JJ (2020) Platelet function testing in neurovascular procedures: tool or gimmick? Interv Neurol 8(2–6):123–134. https://doi.org/10.1159/000496702
doi: 10.1159/000496702 pubmed: 32508894
FitzGerald R, Pirmohamed M (2011) Aspirin resistance: effect of clinical, biochemical and genetic factors. Pharmacol Ther 130(2):213–225. https://doi.org/10.1016/j.pharmthera.2011.01.011
doi: 10.1016/j.pharmthera.2011.01.011 pubmed: 21295071
Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES, MaxDonald RL, Mayer SA (2006) Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 59(1):21–27. https://doi.org/10.1227/01.NEU.0000218821.34014.1B
doi: 10.1227/01.NEU.0000218821.34014.1B pubmed: 16823296
Gard AP, Sayles BD, Robbins JW, Thorell WE, Surdell DL (2017) Hemorrhage rate after external ventricular drain placement in subarachnoid hemorrhage: time to heparin administration. Neurocrit Care 27(3):350–355. https://doi.org/10.1007/s12028-017-0417-4
doi: 10.1007/s12028-017-0417-4 pubmed: 28612132
Hoh BL, Nogueira RG, Ledezma CJ, Pryor JC, Ogilvy CS (2005) Safety of heparinization for cerebral aneurysm coiling soon after external ventriculostomy drain placement. Neurosurgery 57(5):845–849. https://doi.org/10.1227/01.neu.0000180814.95032.07
doi: 10.1227/01.neu.0000180814.95032.07 pubmed: 16284554
Hudson JS, Nagahama Y, Nakagawa D et al (2018) Hemorrhage associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on a regimen of dual antiplatelet therapy: a retrospective analysis. J Neurosurg 129(4):916–921. https://doi.org/10.3171/2017.5.JNS17642
doi: 10.3171/2017.5.JNS17642 pubmed: 29125410
Hudson JS, Prout BS, Nagahama Y et al (2019) External ventricular drain and hemorrhage in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy: a retrospective cohort study. Neurosurgery 84(2):479–484. https://doi.org/10.1093/neuros/nyy127
doi: 10.1093/neuros/nyy127 pubmed: 29660038
Hunt WE, Hess RM (1968) Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28(1):14–20. https://doi.org/10.3171/jns.1968.28.1.0014
doi: 10.3171/jns.1968.28.1.0014 pubmed: 5635959
Kim S, Choi JH, Kang M, Cha JK, Huh JT (2016) Safety and efficacy of intravenous tirofiban as antiplatelet premedication for stent-assisted coiling in acutely ruptured intracranial aneurysms. AJNR Am J Neuroradiol 37(3):508–551. https://doi.org/10.3174/ajnr.A4551
doi: 10.3174/ajnr.A4551 pubmed: 26471748 pmcid: 7960136
Kung DK, Policeni BA, Capuano AW, Rossen JD, Jabbour PM, Torner JC, Howard MA, Hasan D (2011) Risk of ventriculostomy-related hemorrhage in patients with acutely ruptured aneurysms treated using stent-assisted coiling: clinical article. J Neurosurg 114(4):1021–1027. https://doi.org/10.3171/2010.9.JNS10445
doi: 10.3171/2010.9.JNS10445 pubmed: 20950080
Leschke JM, Lozen A, Kaushal M, Oni-Orisan A, Noufal M, Zaidat O, Pollock GA, Mueller WM (2017) Hemorrhagic complications associated with ventriculostomy in patients undergoing endovascular treatment for intracranial aneurysms: a single-center experience. Neurocrit Care 27(1):11–16. https://doi.org/10.1007/s12028-016-0350-y
doi: 10.1007/s12028-016-0350-y pubmed: 28000128
Lim YC, Shim YS, Oh SY, Kim MJ, Park KY, Chung J (2019) External ventricular drainage before endovascular treatment in patients with aneurysmal subarachnoid hemorrhage in acute period: its relation to hemorrhagic complications. Neurointervention 14(1):35–42. https://doi.org/10.5469/neuroint.2018.01067
doi: 10.5469/neuroint.2018.01067 pubmed: 30636388 pmcid: 6433188
Ospel JM, Brouwer P, Dorn F, Arthur A, Jensen ME, Nogueira R, Chapot R, Albuquerque F, Majoie C (2020) Antiplatelet management for stent-assisted coiling and flow diversion of ruptured intracranial aneurysms: a delphi consensus statement. AJNR Am J Neuroradiol 41(10):1856–1862. https://doi.org/10.3174/ajnr.A6814
doi: 10.3174/ajnr.A6814 pubmed: 32943417 pmcid: 7661082
Scheller C, Strauss C, Prell J, Simmermacher S, Brandt S (2018) Increased rate of ventriculostomy-related hemorrhage following endovascular treatment of ruptured aneurysms compared to clipping. Acta Neurochir (Wien) 160(3):545–550. https://doi.org/10.1007/s00701-018-3471-6
doi: 10.1007/s00701-018-3471-6
Scholz C, Hubbe U, Deininger M, Deininger MH (2013) Hemorrhage rates of external ventricular drain (EVD), intracranial pressure gauge (ICP) or combined EVD and ICP gauge placement within 48 h of endovascular coil embolization of cerebral aneurysms. Clin Neurol Neurosurg 115(8):1399–1402. https://doi.org/10.1016/j.clineuro.2013.01.023
doi: 10.1016/j.clineuro.2013.01.023 pubmed: 23428140
Qin G, Pang G, Zhong S, Chen H, Tang X, Lan S (2021) Increased risk of ventriculostomy-associated hemorrhage in patients treated with antiplatelet agents for stent-assisted coiling of ruptured intracranial aneurysms. Br J Neurosurg 35(3):270–274. https://doi.org/10.1080/02688697.2020.1787338
doi: 10.1080/02688697.2020.1787338 pubmed: 32643426
Roh H, Kim J, Bae H, Chong K, Kim JH, Suh S, il, Kwon TH, Yoon W, (2020) Comparison of stent-assisted and no-stent coil embolization for safety and effectiveness in the treatment of ruptured intracranial aneurysms. J Neurosurg 133(3):814–820. https://doi.org/10.3171/2019.5.JNS19988
doi: 10.3171/2019.5.JNS19988
Vance AZ, Jayaraman MV, Dubel GJ, Doberstein CE, Haas RA (2009) Safety of intravenous heparin administration after endovascular treatment for ruptured intracranial aneurysms. J Neurointerv Surg 1(2):136–141. https://doi.org/10.1136/jnis.2009.000570
doi: 10.1136/jnis.2009.000570 pubmed: 21994283
Yan Y, He X, Fang Y, Xu Y, Hong B, Liu J, Huang Q (2021) The safety and efficacy of low-dosage tirofiban for stent-assisted coiling of ruptured intracranial aneurysms. Neurosurg Rev 44(4):2211–2218. https://doi.org/10.1007/s10143-020-01398-w
doi: 10.1007/s10143-020-01398-w pubmed: 32989479
Yoon CH, Lee HW, Kim YS, Lee SW, Yeom JA, Roh J, Baik SK (2018) Preliminary study of tirofiban infusion in coil embolization of ruptured intracranial aneurysms. Neurosurgery 82(1):76–84. https://doi.org/10.1093/neuros/nyx177
doi: 10.1093/neuros/nyx177 pubmed: 28419294

Auteurs

Moritz Lenschow (M)

Center for Neurosurgery, University Hospital of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany. moritz.lenschow@uk-koeln.de.

Niklas von Spreckelsen (N)

Center for Neurosurgery, University Hospital of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany.

Sergej Telentschak (S)

Center for Neurosurgery, University Hospital of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany.

Christoph Kabbasch (C)

Department of Neuroradiology, University Hospital of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany.

Roland Goldbrunner (R)

Center for Neurosurgery, University Hospital of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany.

Stefan Grau (S)

Center for Neurosurgery, University Hospital of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH